Lifespan-extending drug given late in life reverses age-related heart disease in mice

June 10, 2013, Buck Institute for Age Research

Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months. The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.

Researchers at the are currently recruiting seniors with cardiac artery disease for a clinical trial involving low dose treatment with .

Rapamycin is an immunosuppressant drug which can be used to help prevent after transplantation. It is also included in for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.

The mice were examined with ultrasound before and after the three-month treatment period - using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related was either slowed or reversed in the treated mice. "When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period," he said. "This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment," added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.

Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. "Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation," said Melov. "We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention."

"Little has been known about the functional ramifications of rapamycin in mammalian tissues," said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. "These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life." He added, "It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life."

Chronic treatment with rapamycin has been problematic in both humans and ; the drug has the potential to cause deleterious metabolic side effects including weight gain and glucose insensitivity. Melov said in this study, the drug had only mild transient metabolic effects. Future studies will focus on better understanding the molecular targets that drive age-related heart dysfunction, and why rapamycin treatment is so beneficial to the aging hearts.

Explore further: Rapamycin effective in mouse model of inherited heart disease and muscular dystrophies

More information: www.clinicaltrials.gov/ct2/sho … rm=Rapamycin&rank=11

Related Stories

Rapamycin effective in mouse model of inherited heart disease and muscular dystrophies

July 25, 2012
Rapamycin, an immunosuppressant drug used in a variety of disease indications and under study in aging research labs around the world, improved function and extended survival in mice suffering from a genetic mutation which ...

Drug trio improved effectiveness of cancer treatment, protected heart

November 6, 2012
Combining cancer medication with a drug for erectile dysfunction and one for heart transplants helped kill cancer cells and protected the heart from damage, in a study presented at the American Heart Association's Scientific ...

Study reveals how cancer drug causes diabetic-like state

April 3, 2012
Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow ageing.

New study explains duality of longevity drug rapamycin

March 29, 2012
A Penn- and MIT-led team explained how rapamycin, a drug that extends mouse lifespan, also causes insulin resistance. The researchers showed in an animal model that they could, in principle, separate the effects, which depend ...

Easter Island drug raises cognition throughout life span

June 29, 2012
Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with ...

Stem-cell-protecting drug could prevent the harmful side effects of radiation therapy

September 6, 2012
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can ...

Recommended for you

Scientists solve the case of the missing subplate, with wide implications for brain science

June 21, 2018
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development. Recently, ...

LincRNAs identified in human fat tissue

June 21, 2018
A large team of researchers from the U.S. and China has succeeded in identifying a number of RNA fragments found in human fat tissue. In their paper published in the journal Science Translational Medicine the group describes ...

Key molecule of aging discovered

June 21, 2018
Every cell and every organism ages sooner or later. But why is this so? Scientists at the German Cancer Research Center in Heidelberg have now discovered for the first time a protein that represents a central switching point ...

Compound made inside human body stops viruses from replicating

June 20, 2018
The newest antiviral drugs could take advantage of a compound made not by humans, but inside them. A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals ...

Research reveals zero proof probiotics can ease your anxiety

June 20, 2018
If you're expecting probiotics to reduce your anxiety, it might be time to put down that yogurt spoon—or supplement bottle—and call a professional instead.

Long-term estrogen therapy changes microbial activity in the gut, study finds

June 20, 2018
Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.